Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Overexpression of Hoxc13 in hair cells causes hair loss and skin issues.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Versican in dermal papilla cells is crucial for healthy hair growth.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Patched1 helps prevent tumors by controlling cell growth.

MCHR2 gene duplications may be linked to alopecia areata.

Phospholipase C-δ1 is crucial for normal hair development.

Pangenome analysis reveals key genes for pig adaptation and traits, aiding genetic improvement.

CT60 polymorphism might increase the risk of Alopecia Areata.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Glypican-1 is important for hair follicle blood vessel growth and could be a target for treating hair loss.

Removing PLCg1 from skin cells caused thicker oil glands and less hair in mice.

Glypican-1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

UC.145 may be a new biomarker for predicting gastric cancer.